ATAI Life Sciences logo

ATAI Life Sciences

ID: 5832416

German life sciences company focused on psychedelic therapies for mental health conditions.

7

Funding Rounds

$482.1m

Money raised

Overview

German life sciences company focused on psychedelic therapies for mental health conditions.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company ATAI Life Sciences has raised a total of $482.1m in funding over 7 rounds.

Key Insights:

  • ATAI Life Sciences Series D round, March 3, 2021: $157m
  • Atai Life Sciences March 2021 Series D Funding Round: $160m
  • ATAI Life Sciences Series C round, November 24, 2020: $93m
  • Atai Life Sciences Funding Round 2019: $43m
  • ATAI Life Sciences Series A round, October 3, 2018: $25.5m
  • ATAI Life Sciences Seed round, June 2018: $3.6m

Subsidiaries

ATAI Life Sciences operates through the following subsidiaries: